1.      Mathers CD;Boerma, T; Ma Fat D (2009) Global and regional causes of death, British medical bulletin 92 7-32

2.      Carden, D, Granger, D, Pathophysiology of ischemia reperfusion injury. J pathol190; 255-256

3.      Folkman J, D Amore PA 1996 Blood vessel formation what is its molecular basiscell87:1153-5

4.      Patan S 2004 Vasculogenesis and angiogenesis. Cancer treat res 117:3-32

5.      Ryu Matsuo, Tet suro Ago, Masahiro kamouchi, Junya Kuroda, Takahiro Kuwashiro.Clinical significance of plasma VEGF value in ischaemic stroke. REBIOS STUDY.BMCneurology2013 13:32.

6.      Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J: Serialmeasurement of vascular endothelial growth factor and transforminggrowth factor-beta1 in serum of patients with acute ischemic stroke.Stroke J Cereb Circ 2000, 31(8):1863–1870.

7.      Wei, M.H.; Popescu, N. C.; Lerman, M. I.; Merrill, M. J.; Zimonjic, D. B. Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12. Hum. Genet. 97: 794-797, 1996

8.      Storkebaum E, Lambrechts D, Carmeliet P: VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004, 26(9):943–954.

9.      Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219(4587):983–985.

10.  Carmeliet P: Angiogenesis in health and disease. Nat Med 2003, 9(6):653–660.

11.  Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA: VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003, 111(12):1843–1851

12.  Hirashima M. Regulation of endothelial cell differentiation and arterial specification by VEGF andNotch signaling. Anat Sci Int. 2009; 84:95–101. [PubMed: 19259767]

13.  Shibuya M. Brain angiogenesis in developmental and pathological processes: therapeutic aspects ofvascular endothelial growth factor. FEBS J. 2009; 276:4636–4643. [PubMed: 19664071]

14.  Schaper W. Collateral circulation: past and present. Basic Res Cardiol. 2009; 104:5–21. [PubMed: 19101749]

15.  Mackenzie F, Ruhrberg C. Diverse roles for VEGF-A in the nervous system. Development. 2012; 139:1371–1380. [PubMed: 22434866]

16.  Ferrara N. 1993 Vascular endothelial growth factor Trends. Cardiovasc Med 3:244–250

17.  Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435–439

18.  Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS, Powell-Braxton L, Hillan KJ, Moore MW 1996 Heterozygous embryonic lethality induced by targeted inactivation of the VEGFgene. Nature 380:439–442

19.  Ferrara N, Henzel WJ 1989 Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851–858.

20.  Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309

21.  Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J 1989 Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470–1478

22.  Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT 1989 Vascular permeability factor, an endothelial cell mitogen related to platelet de-rived growth factor. Science 246:1309–1312

23.  Plouet J, Schilling J, Gospodarowicz D 1989 Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 8:3801–3806

24.  Conn G, Bayne M, Soderman L, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA 1990 Amino acid and cDNA sequence of a vascular endothelial cell mitogen homologous to plateletderived growth factor. Proc Natl Acad Sci USA 87:2628–2632

25.  Marti HH, Risau W: Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA 1998, 95:15809–15814

26.  Monacci WT, Merrill MJ, Oldfield EH: Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993, 264:C995–C1002

27.  Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4–25

28.  Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor (VEGF) in C6 glioma cells. J Biol Chem 1995, 270: 19761–19766

29.  Gleadle JM, Ebert BL, Firth JD, Ratcliffe PJ: Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 1995, 268:C1362–C1368

30.  Marti HH, Risau W: Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA 1998, 95:15809–15814.

31.  Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995, 270:13333–13340

32.  Liu Y, Cox SR, Morita T, Kourembanas S: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5_ enhancer. Circ Res 1995, 77:638–643

33.  Forsythe JA, Jiang B-H, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16:4604–4613

34.  Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor (VEGF) in C6 glioma cells. J Biol Chem 1995, 270:19761–19766

35.  Levy AP, Levy NS, Goldberg MA: Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996, 271:2746–2753

36.  Levy NS, Chung S, Furneaux H, Levy AP: Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 1998, 273:6417–6423

37.  Stein I, Itin A, Einat P, Skaliter R, Grossman Z, Keshet E: Translation of vascu-lar endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 1998, 18:3112–3119

38.  Tian H, McKnight SL, Russell DW: Endothelial pas domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997, 11:72–82

39.  Flamme I, Frohlich T, von Reutern M, Kappel A, Damert A, Risau W: HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1_ and developmentally expressed in blood vessels. Mech Dev 1997, 63:51–60

40.  Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y: A novel bHLH-PAS factor with close sequence similarity to hypoxiainducible factor 1 regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA1997, 94:4273–4278.

41.  Kappel A, Ronicke V, Damert A, Flamme I, Risau W, Breier G: Identification of vascular endothelial growth factor (VEGF) receptor-2(Flk-1) promoter/enhancer sequences sufficient for angioblast andendothelial cell-specific transcription in transgenic mice. Blood 1999,93:4284–4292

42.  Gonchar IA, Prudyvus IS, Stepanova IuI. Vascular endothelial growth factor expression in patients with acute ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113:25–29.

43.  Lee SC, Lee KY, Kim YJ, Kim SH, Koh SH, Lee YJ. Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis. Eur J Neurol. 2010;17:45–51.